Ignite Creation Date:
2024-05-06 @ 8:25 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06379217
Status:
RECRUITING
Last Update Posted:
2024-06-20
First Post:
2024-03-04
Brief Title:
NEPC Study An Exploratory Safety and Efficacy Study With PSMA SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer
Sponsor:
Organization:
Novartis